Bruker Co. (NASDAQ:BRKR) Shares Sold by State of Alaska Department of Revenue

State of Alaska Department of Revenue trimmed its holdings in Bruker Co. (NASDAQ:BRKR) by 0.5% during the fourth quarter, HoldingsChannel.com reports. The firm owned 42,471 shares of the medical research company’s stock after selling 215 shares during the period. State of Alaska Department of Revenue’s holdings in Bruker were worth $2,488,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in BRKR. True Wealth Design LLC grew its stake in Bruker by 4,636.4% in the third quarter. True Wealth Design LLC now owns 521 shares of the medical research company’s stock worth $36,000 after purchasing an additional 510 shares in the last quarter. Eagle Bay Advisors LLC raised its position in shares of Bruker by 2,324.1% during the 4th quarter. Eagle Bay Advisors LLC now owns 703 shares of the medical research company’s stock valued at $41,000 after acquiring an additional 674 shares in the last quarter. UMB Bank n.a. lifted its stake in Bruker by 115.3% during the third quarter. UMB Bank n.a. now owns 661 shares of the medical research company’s stock worth $46,000 after purchasing an additional 354 shares during the last quarter. GAMMA Investing LLC increased its stake in Bruker by 81.0% during the third quarter. GAMMA Investing LLC now owns 867 shares of the medical research company’s stock valued at $60,000 after purchasing an additional 388 shares during the last quarter. Finally, Values First Advisors Inc. acquired a new stake in shares of Bruker during the third quarter worth $73,000. 79.52% of the stock is currently owned by hedge funds and other institutional investors.

Bruker Price Performance

NASDAQ BRKR opened at $51.13 on Tuesday. The firm has a market capitalization of $7.75 billion, a PE ratio of 24.58, a P/E/G ratio of 3.81 and a beta of 1.16. The company has a debt-to-equity ratio of 1.24, a current ratio of 1.66 and a quick ratio of 0.73. Bruker Co. has a 12 month low of $48.07 and a 12 month high of $94.86. The company’s 50 day simple moving average is $58.18 and its 200 day simple moving average is $60.95.

Bruker Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, December 16th. Stockholders of record on Monday, December 2nd were issued a $0.05 dividend. The ex-dividend date was Monday, December 2nd. This represents a $0.20 annualized dividend and a dividend yield of 0.39%. Bruker’s dividend payout ratio (DPR) is 9.62%.

Wall Street Analysts Forecast Growth

BRKR has been the topic of a number of recent research reports. Guggenheim reissued a “buy” rating on shares of Bruker in a report on Friday, January 17th. Barclays reduced their price objective on Bruker from $69.00 to $65.00 and set an “overweight” rating for the company in a research report on Monday. Wells Fargo & Company cut their target price on Bruker from $78.00 to $75.00 and set an “overweight” rating on the stock in a research note on Wednesday, November 6th. Bank of America upped their price target on shares of Bruker from $78.00 to $80.00 and gave the stock a “buy” rating in a research report on Friday, December 13th. Finally, Citigroup cut their price objective on shares of Bruker from $80.00 to $75.00 and set a “buy” rating on the stock in a research report on Wednesday, November 6th. Six equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $74.09.

Insider Activity at Bruker

In other Bruker news, CEO Frank H. Laukien acquired 100,000 shares of the stock in a transaction dated Monday, November 18th. The shares were bought at an average price of $50.14 per share, with a total value of $5,014,000.00. Following the purchase, the chief executive officer now directly owns 38,439,563 shares of the company’s stock, valued at approximately $1,927,359,688.82. This trade represents a 0.26 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 28.30% of the company’s stock.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.